CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Shares withheld for taxes | −348 | $60.93 | $21K | 5,544 |
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Exercise or conversion | +812 | 6,356 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Other acquisition | +15 | 6,371 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Shares withheld for taxes | −260 | $60.93 | $16K | 6,111 |
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Exercise or conversion | +3,751 | 9,862 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Other acquisition | +730 | 10,592 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Shares withheld for taxes | −1,405 | $60.93 | $86K | 9,187 |
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Exercise or conversion · Market Share Units | −625 | 626 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Exercise or conversion · Market Share Units | −946 | 1,892 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Exercise or conversion · Market Share Units | −812 | 2,438 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Grant or award · Market Share Units | +3,265 | 3,265 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Exercise or conversion · Performance Shares | −3,751 | 0 | ||
| 2021-03-10 | Eid Joseph SVP,Head Glob. Medical Affairs | Grant or award · Performance Shares | +4,898 | 4,898 | ||
| 2021-03-10 | Elkins David V EVP, Chief Financial Officer | Exercise or conversion | +8,025 | 91,211 | ||
| 2021-03-10 | Elkins David V EVP, Chief Financial Officer | Other acquisition | +150 | 91,361 | ||
| 2021-03-10 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −4,329 | $60.93 | $264K | 87,032 |
| 2021-03-10 | Elkins David V EVP, Chief Financial Officer | Exercise or conversion · Market Share Units | −8,025 | 24,077 | ||
| 2021-03-10 | Elkins David V EVP, Chief Financial Officer | Grant or award · Market Share Units | +32,171 | 32,171 | ||
| 2021-03-10 | Elkins David V EVP, Chief Financial Officer | Grant or award · Performance Shares | +48,257 | 48,257 | ||
| 2021-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion | +4,189 | 9,082 |
Page 77 of 90 · 1,795 trades